Cargando…
Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform
We describe the development and characterization of a mouse and human epithelial cell monolayer platform of the small and large intestines, with a broad range of potential applications including the discovery and development of minimally systemic drug candidates. Culture conditions for each intestin...
Autores principales: | Kozuka, Kenji, He, Ying, Koo-McCoy, Samantha, Kumaraswamy, Padmapriya, Nie, Baoming, Shaw, Karen, Chan, Priscilla, Leadbetter, Michael, He, Limin, Lewis, Jason G., Zhong, Ziyang, Charmot, Dominique, Balaa, Marwan, King, Andrew J., Caldwell, Jeremy S., Siegel, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785676/ https://www.ncbi.nlm.nih.gov/pubmed/29153987 http://dx.doi.org/10.1016/j.stemcr.2017.10.013 |
Ejemplares similares
-
Discovery of Tenapanor: A First-in-Class Minimally
Systemic Inhibitor of Intestinal Na(+)/H(+) Exchanger
Isoform 3
por: Jacobs, Jeffrey W., et al.
Publicado: (2022) -
Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice
por: Finn, Patricia D., et al.
Publicado: (2019) -
Non-Systemic Drugs: A Critical Review
por: Charmot, Dominique
Publicado: (2012) -
Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice
por: Davidson, James P., et al.
Publicado: (2017) -
Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
por: Johansson, Susanne, et al.
Publicado: (2016)